vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and NEXSTAR MEDIA GROUP, INC. (NXST). Click either name above to swap in a different company.

NEXSTAR MEDIA GROUP, INC. is the larger business by last-quarter revenue ($1.3B vs $962.7M, roughly 1.3× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -12.9%, a 20.6% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -13.4%). NEXSTAR MEDIA GROUP, INC. produced more free cash flow last quarter ($136.0M vs $96.9M). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs 0.2%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Nexstar Media Group, Inc. is an American publicly traded media company with headquarters in Irving, Texas; Midtown Manhattan; and Chicago. Founded on June 17, 1996, the company is the largest television station owner in the United States, owning 197 television stations across the United States, most of which are affiliated with the four major American television networks and MyNetworkTV in markets as large as New York City and as small as San Angelo, Texas. It also operates all of the station...

ATR vs NXST — Head-to-Head

Bigger by revenue
NXST
NXST
1.3× larger
NXST
$1.3B
$962.7M
ATR
Growing faster (revenue YoY)
ATR
ATR
+27.0% gap
ATR
13.5%
-13.4%
NXST
Higher net margin
ATR
ATR
20.6% more per $
ATR
7.7%
-12.9%
NXST
More free cash flow
NXST
NXST
$39.1M more FCF
NXST
$136.0M
$96.9M
ATR
Faster 2-yr revenue CAGR
ATR
ATR
Annualised
ATR
2.6%
0.2%
NXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
NXST
NXST
Revenue
$962.7M
$1.3B
Net Profit
$74.3M
$-166.0M
Gross Margin
Operating Margin
11.0%
18.7%
Net Margin
7.7%
-12.9%
Revenue YoY
13.5%
-13.4%
Net Profit YoY
-26.4%
-168.6%
EPS (diluted)
$1.13
$-5.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
NXST
NXST
Q4 25
$962.7M
$1.3B
Q3 25
$961.1M
$1.2B
Q2 25
$966.0M
$1.2B
Q1 25
$887.3M
$1.2B
Q4 24
$848.1M
$1.5B
Q3 24
$909.3M
$1.4B
Q2 24
$910.1M
$1.3B
Q1 24
$915.4M
$1.3B
Net Profit
ATR
ATR
NXST
NXST
Q4 25
$74.3M
$-166.0M
Q3 25
$127.9M
$70.0M
Q2 25
$111.7M
$97.0M
Q1 25
$78.8M
$108.0M
Q4 24
$100.9M
$242.0M
Q3 24
$100.0M
$187.0M
Q2 24
$90.5M
$118.0M
Q1 24
$83.1M
$175.0M
Operating Margin
ATR
ATR
NXST
NXST
Q4 25
11.0%
18.7%
Q3 25
14.2%
14.6%
Q2 25
14.9%
17.3%
Q1 25
12.8%
17.8%
Q4 24
14.2%
28.1%
Q3 24
15.2%
24.5%
Q2 24
13.8%
18.9%
Q1 24
12.2%
21.4%
Net Margin
ATR
ATR
NXST
NXST
Q4 25
7.7%
-12.9%
Q3 25
13.3%
5.8%
Q2 25
11.6%
7.9%
Q1 25
8.9%
8.8%
Q4 24
11.9%
16.3%
Q3 24
11.0%
13.7%
Q2 24
9.9%
9.3%
Q1 24
9.1%
13.6%
EPS (diluted)
ATR
ATR
NXST
NXST
Q4 25
$1.13
$-5.57
Q3 25
$1.92
$2.14
Q2 25
$1.67
$3.06
Q1 25
$1.17
$3.37
Q4 24
$1.48
$7.44
Q3 24
$1.48
$5.27
Q2 24
$1.34
$3.54
Q1 24
$1.23
$5.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
NXST
NXST
Cash + ST InvestmentsLiquidity on hand
$409.5M
$280.0M
Total DebtLower is stronger
$1.1B
$6.3B
Stockholders' EquityBook value
$2.7B
$2.1B
Total Assets
$5.3B
$10.8B
Debt / EquityLower = less leverage
0.43×
3.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
NXST
NXST
Q4 25
$409.5M
$280.0M
Q3 25
$264.8M
$236.0M
Q2 25
$169.8M
$234.0M
Q1 25
$136.8M
$253.0M
Q4 24
$226.2M
$144.0M
Q3 24
$327.9M
$181.0M
Q2 24
$223.9M
$146.0M
Q1 24
$201.1M
$237.0M
Total Debt
ATR
ATR
NXST
NXST
Q4 25
$1.1B
$6.3B
Q3 25
$546.0M
$6.4B
Q2 25
$535.1M
$6.4B
Q1 25
$561.2M
$6.5B
Q4 24
$688.1M
$6.5B
Q3 24
$822.7M
$6.7B
Q2 24
$681.5M
$6.8B
Q1 24
$680.4M
$6.8B
Stockholders' Equity
ATR
ATR
NXST
NXST
Q4 25
$2.7B
$2.1B
Q3 25
$2.8B
$2.3B
Q2 25
$2.7B
$2.3B
Q1 25
$2.5B
$2.2B
Q4 24
$2.5B
$2.3B
Q3 24
$2.5B
$2.2B
Q2 24
$2.4B
$2.3B
Q1 24
$2.3B
$2.3B
Total Assets
ATR
ATR
NXST
NXST
Q4 25
$5.3B
$10.8B
Q3 25
$5.1B
$11.2B
Q2 25
$4.9B
$11.3B
Q1 25
$4.5B
$11.4B
Q4 24
$4.4B
$11.5B
Q3 24
$4.6B
$11.7B
Q2 24
$4.5B
$11.8B
Q1 24
$4.4B
$11.9B
Debt / Equity
ATR
ATR
NXST
NXST
Q4 25
0.43×
3.07×
Q3 25
0.20×
2.78×
Q2 25
0.20×
2.83×
Q1 25
0.22×
2.89×
Q4 24
0.28×
2.89×
Q3 24
0.32×
3.02×
Q2 24
0.28×
2.99×
Q1 24
0.29×
2.93×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
NXST
NXST
Operating Cash FlowLast quarter
$183.7M
$190.0M
Free Cash FlowOCF − Capex
$96.9M
$136.0M
FCF MarginFCF / Revenue
10.1%
10.6%
Capex IntensityCapex / Revenue
9.0%
4.2%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$743.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
NXST
NXST
Q4 25
$183.7M
$190.0M
Q3 25
$177.6M
$117.0M
Q2 25
$126.0M
$247.0M
Q1 25
$82.7M
$337.0M
Q4 24
$178.2M
$411.0M
Q3 24
$229.3M
$387.0M
Q2 24
$143.6M
$176.0M
Q1 24
$92.3M
$276.0M
Free Cash Flow
ATR
ATR
NXST
NXST
Q4 25
$96.9M
$136.0M
Q3 25
$114.3M
$87.0M
Q2 25
$62.5M
$218.0M
Q1 25
$25.9M
$302.0M
Q4 24
$112.2M
$376.0M
Q3 24
$162.7M
$358.0M
Q2 24
$75.4M
$139.0M
Q1 24
$16.7M
$232.0M
FCF Margin
ATR
ATR
NXST
NXST
Q4 25
10.1%
10.6%
Q3 25
11.9%
7.3%
Q2 25
6.5%
17.7%
Q1 25
2.9%
24.5%
Q4 24
13.2%
25.3%
Q3 24
17.9%
26.2%
Q2 24
8.3%
11.0%
Q1 24
1.8%
18.1%
Capex Intensity
ATR
ATR
NXST
NXST
Q4 25
9.0%
4.2%
Q3 25
6.6%
2.5%
Q2 25
6.6%
2.4%
Q1 25
6.4%
2.8%
Q4 24
7.8%
2.4%
Q3 24
7.3%
2.1%
Q2 24
7.5%
2.9%
Q1 24
8.3%
3.4%
Cash Conversion
ATR
ATR
NXST
NXST
Q4 25
2.47×
Q3 25
1.39×
1.67×
Q2 25
1.13×
2.55×
Q1 25
1.05×
3.12×
Q4 24
1.77×
1.70×
Q3 24
2.29×
2.07×
Q2 24
1.59×
1.49×
Q1 24
1.11×
1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

NXST
NXST

Distribution Service$704.0M55%
Advertising$491.0M38%
Other$78.0M6%
Corporate$3.0M0%

Related Comparisons